Antioxidative potential of a combined therapy of anti TNFα and Zn acetate in experimental colitis

World Journal of Gastroenterology

Volumn 17, Issue 36, 2011, Pages 4099-4103

  Barollo, Michela ^a   Medici, Valentina ^b   D'Incà, Renata ^a   Banerjee, Antara ^a   Ingravallo, Giuseppe ^c   Scarpa, Marco ^d   Patak, Surajit ^a   Ruffolo, Cesare ^a   Cardin, Romilda ^a   Sturniolo, Giacomo Carlo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF BARI   (Italy)

^d VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

Anti tumor necrosis factor ; Experimental colitis; Inflammatory bowel disease; Oxidative dam age; Zinc

Indexed keywords

DEXTRAN SULFATE; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; ZINC ACETATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL INFILTRATION; CLINICAL FEATURE; COLITIS; COLON MUCOSA; COLON ULCER; CONTROLLED STUDY; DNA ADDUCT; ENZYME ACTIVITY; HOMOGENATE; INFLAMMATION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; SHAM PROCEDURE;

EID: 80155161338     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v17.i36.4099     Document Type: Article

References (30)

1. Torres MI, Rios A. Current view of the immunopathogenesis in inflammatory bowel disease and its implications for therapy. World J Gastroenterol 2008; 14: 1972-1980
2. Sanchez-Munoz F, Dominguez-Lopez A, Yamamoto-Fuzhou JK. Role of cytokines in inflammatory bowel disease. World J Gastroenterol 2008; 14: 4280-4288
3. Nielsen OH, Vainer B, Madsen SM, Seidelin JB, Heegaard NH. Established and emerging biological activity markers of inflammatory bowel disease. Am J Gastroenterol 2000; 95: 359-367
4. Shanahan F. Crohn's disease. Lancet 2000; 359: 62-69
5. Papadakis KA, Targan SR. Tumor necrosis factor: biology and therapeutic inhibitors. Gastroenterology 2000; 119: 1148-1157
6. Worledge KL, Godiska R, Barrett TA, Kink JA. Oral administration of avian tumor necrosis factor antibodies effectively treats experimental colitis in rats. Dig Dis Sci 2000; 45: 2298-2305
7. Akobeng AK, Zachos M. Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease. Cochrane Database Syst Rev 2004; CD003574
8. Filippi J, Al-Jaouni R, Wiroth JB, Hébuterne X, Schneider SM. Nutritional deficiencies in patients with Crohn's disease in remission. Inflamm Bowel Dis 2006; 12: 185-191
9. Troskot B, Simicevic VN, Dodig M, Rotkvic I, Ivankovic D, Duvnjak M. The protective effect of zinc sulphate pretreatment against duodenal ulcers in the rat. Biometals 1997; 10: 325-329
10. Bucci I, Napolitano G, Giuliani C, Lio S, Minnucci A, Di Giacomo F, Calabrese G, Sabatino G, Palka G, Monaco F. Zinc sulfate supplementation improves thyroid function in hypoz incemic Down children. Biol Trace Elem Res 1999; 67: 257-268
11. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989; 96: 795-803
12. Jenkins D, Balsitis M, Gallivan S, Dixon MF, Gilmour HM, Shepherd NA, Theodossi A, Williams GT. Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of Gastroenterology Initiative. J Clin Pathol 1997; 50: 93-105
13. Tanaka M, Riddell RH, Saito H, Soma Y, Hidaka H, Kudo H. Morphologic criteria applicable to biopsy specimens for effective distinction of inflammatory bowel disease from other forms of colitis and of Crohn's disease from ulcerative colitis. Scand J Gastroenterol 1999; 34: 55-67
14. Krawisz JE, Sharon P, Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 1984; 87: 1344-1350
15. Helbock HJ, Beckman KB, Shigenaga MK, Walter PB, Woodall AA, Yeo HC, Ames BN. DNA oxidation matters: the HPLC-electrochemical detection assay of 8-oxo-deoxyguanosine and 8-oxo-guanine. Proc Natl Acad Sci USA 1998; 95: 288-293
16. Di Leo V, D'Incà R, Barollo M, Tropea A, Fries W, Mazzon E, Irato P, Cecchetto A, Sturniolo GC. Effect of zinc supplementation on trace elements and intestinal metallothionein concentrations in experimental colitis in the rat. Dig Liver Dis 2001; 33: 135-139
17. Sturniolo GC, Di Leo V, Ferronato A, D'Odorico A, D'Incà R. Zinc supplementation tightens "leaky gut" in Crohn's disease. Inflamm Bowel Dis 2001; 7: 94-98
18. Chen BW, Wang HH, Liu JX, Liu XG. Zinc sulphate solution enema decreases inflammation in experimental colitis in rats. J Gastroenterol Hepatol 1999; 14: 1088-1092
19. Sturniolo GC, Fries W, Mazzon E, Di Leo V, Barollo M, D'Inca R. Effect of zinc supplementation on intestinal permeability in experimental colitis. J Lab Clin Med 2002; 139: 311-315
20. Blam ME, Stein RB, Lichtenstein GR. Integrating anti-tumor necrosis factor therapy in inflammatory bowel disease: current and future perspectives. Am J Gastroenterol 2001; 96: 1977-1997
21. Triantafillidis JK, Papalois AE, Parasi A, Anagnostakis E, Burnazos S, Gikas A, Merikas EG, Douzinas E, Karagianni M, Sotiriou H. Favorable response to subcutaneous administration of infliximab in rats with experimental colitis. World J Gastroenterol 2005; 11: 6843-6847
22. Videla S, García-Lafuente A, Antolín M, Vilaseca J, Guarner F, Crespo E, González G, Salas A, Malagelada JR. Antitumor necrosis factor therapy in rat chronic granulomatous colitis: critical dose-timing effects on outcome. J Pharmacol Exp Ther 1998; 287: 854-859
23. Tran CD, Ball JM, Sundar S, Coyle P, Howarth GS. The role of zinc and metallothionein in the dextran sulfate sodium induced colitis mouse model. Dig Dis Sci 2007; 52: 2113-2121
24. Luk HH, Ko JK, Fung HS, Cho CH. Delineation of the protective action of zinc sulfate on ulcerative colitis in rats. Eur J Pharmacol 2002; 443: 197-204
25. Koningsberger JC, van Asbeck BS, van Faassen E, Wiegman LJ, van Hattum J, van Berge Henegouwen GP, Marx JJ. Copper, zinc-superoxide dismutase and hydrogen peroxide: a hydroxyl radical generating system. Clin Chim Acta 1994; 230: 51-61
26. Yim MB, Chock PB, Stadtman ER. Copper, zinc superoxide dismutase catalyzes hydroxyl radical production from hy drogen peroxide. Proc Natl Acad Sci USA 1990; 87: 5006-5010
27. Lih-Brody L, Powell SR, Collier KP, Reddy GM, Cerchia R, Kahn E, Weissman GS, Katz S, Floyd RA, McKinley MJ, Fisher SE, Mullin GE. Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Dig Dis Sci 1996; 41: 2078-2086
28. Popivanova BK, Kitamura K, Wu Y, Kondo T, Kagaya T, Kaneko S, Oshima M, Fujii C, Mukaida N. Blocking TNFalpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J Clin Invest 2008; 118: 560-570
29. Obermeier F, Kojouharoff G, Hans W, Schölmerich J, Gross V, Falk W. Interferon-gamma (IFN-gamma)and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice. Clin Exp Immunol 1999; 116: 238-245
30. Mulder TP, van der Sluys Veer A, Verspaget HW, Griffioen G, Peña AS, Janssens AR, Lamers CB. Effect of oral zinc supplementation on metallothionein and superoxide dismutase concentrations in patients with inflammatory bowel disease. J Gastroenterol Hepatol 1994; 9: 472-477